BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Events calendar : University of Miami Miller School of Medicine - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://events.med.miami.edu
X-WR-CALDESC:Events for Events calendar : University of Miami Miller School of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261020T120000
DTEND;TZID=America/New_York:20261020T130000
DTSTAMP:20261014T150252Z
CREATED:20260909T204951Z
LAST-MODIFIED:20261014T150252Z
UID:10003794-1792497600-1792501200@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds – "Developing Frameworks for Early Identification and Management of TLS" - Mitchell S. Cairo MD
DESCRIPTION:Department of Pediatrics Grand Rounds \nDeveloping Frameworks for Early Identification and Management of TLS \nMitchell S. Cairo\, M.D. · October 20\, 2026 \n\n \n\n\nDate \nTuesday\, October 20\, 2026 \n\n\nTime \n12:00 p.m. – 1:00 p.m. \n\n\nLocation \nMailman Center\, 8th Floor Auditorium \n\n\n \n\nSpeaker\n \n\nMitchell S. Cairo\, M.D.\nChief\, Pediatric Hematology\, Oncology\, and Stem Cell Transplantation \nDirector\, Children and Adolescent Cancer and Blood Diseases Center \nMedical and Scientific Director\, WMC Cellular and Tissue Engineering Laboratory \nMedical Director\, WMC Hematotherapy Program \nVice Chairman\, Department of Pediatrics \nProfessor of Pediatrics\, Medicine\, Pathology\, Microbiology & Immunology\, and Cell and Molecular Physiology \nMaria Fareri Children’s Hospital \nWestchester Medical Center (WMC) \nNew York Medical College \n\n\n\n \n\nLocation\n\nMailman Center \n8th Floor Auditorium\n1601 NW 12th Ave\nMiami\, FL 33136 \nGet Directions \n\n\n \n\nQuestions\n\nContact Nicole Llerena at nxl320@med.miami.edu. \n\n\n \n\nEvent Category \nPediatrics
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-developing-frameworks-for-early-identification-and-management-of-tls-mitchell-s-cairo-md/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261016T080000
DTEND;TZID=America/New_York:20261016T090000
DTSTAMP:20261014T144828Z
CREATED:20261014T140229Z
LAST-MODIFIED:20261014T144828Z
UID:10003841-1792137600-1792141200@events.med.miami.edu
SUMMARY:The RAS Revolution in Pancreas Cancer | Peter Hosein\, M.D.
DESCRIPTION:Hematology / Medical Oncology Grand Rounds \nThe RAS Revolution in Pancreas Cancer \nPeter Hosein\, M.D. · October 16\, 2026 \n\n \n\n\nDate \nFriday\, October 16\, 2026 \n\n\nTime \n8:00 a.m. – 9:00 a.m. \n\n\nFormat \nVirtual (Zoom) \n\n\n \nJoin Zoom\n \n\nSpeaker\n \n\nPeter Hosein\, M.D.\nProfessor of Medicine \nUniversity of Miami \nDr. Hosein is a board-certified medical oncologist with a primary clinical and research focus in gastrointestinal (GI) cancers\, with 13 years of post-fellowship academic experience in this area. At the University of Miami’s NCI-designated Sylvester Comprehensive Cancer Center\, he is an Associate Professor in the Department of Medicine and the co-director of the GI cancer site disease group\, where he oversees\, organizes\, and prioritizes the clinical trials portfolio for GI malignancies. \n\n\n\n \n\nHow to Join\n\nThis session is held on Zoom. Join at 8:00 a.m. on the day of the session. \nJoin Zoom \n\n\n \n\nTarget Audience\nFaculty\, primary care physicians\, APRNs\, and PharmDs. \n\n \n\nAccreditation and Credit\n\nThe University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nSuccessful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. \n\n\n \n\nDisclosures\nFaculty Disclosure \nDr. Hosein has indicated he has the following relevant financial relationships with ineligible companies: \n\n\n\nFinancial Relationship\nCommercial Interest / Organization\n\n\n\n\nAdvisor\nRevolution Medicines\, Cantargia\n\n\nAdvisory Committees\nElicio Therapeutics\, BetaGlue Therapeutics\n\n\n\nPlanning Committee Disclosure \nDr. Lekakis has indicated that he has no relevant financial relationships with commercial interests. \n\n \n\nEvent Categories \nDept. of Medicine · Hematology · Medical Oncology
URL:https://events.med.miami.edu/event/the-ras-revolution-in-pancreas-cancer-peter-hosein-md/
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
LOCATION:https://miami.zoom.us/j/93768326731?from=addon
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261014T170000
DTEND;TZID=America/New_York:20261014T180000
DTSTAMP:20260915T174131Z
CREATED:20260915T173946Z
LAST-MODIFIED:20260915T174131Z
UID:10003801-1791997200-1792000800@events.med.miami.edu
SUMMARY:Dean's Distinguished Lecture:  Drug Pioneer and Trailblazer Dr. Raymond Schinazi
DESCRIPTION:Ending Hepatitis B: Charting the Path to Elimination\nOctober 14: 5-6 p.m. | Lois Pope Life Center\, 7th Floor Auditorium\nMark your calendars for the upcoming Dean Henri Ford’s Distinguished Lecture Series\, featuring Raymond F. Schinazi\, Ph.D.\, a renowned leader in drug discovery. Dr. Schinazi will explore the global burden of hepatitis B and the limitations of current antiviral therapies\, while examining emerging strategies toward a cure. His lecture will highlight the potential of combination therapies and immunomodulators to improve cure rates and shape the future of hepatitis B treatment in 2026 and beyond. \n \nDr. Raymond F. Schinazi is the Frances Winship Walters Professor of Pediatrics at Emory University and founder and director of the Laboratory of Biochemical Pharmacology. An internationally recognized leader in antiviral drug development\, he has published more than 600 peer-reviewed papers and helped develop six FDA-approved antiviral and immunological therapies. His laboratory is known for major treatments for HIV and hepatitis C\, including Lamivudine\, Emtricitabine\, and Sofosbuvir. Dr. Schinazi has received numerous honors for his contributions to medicine\, including France’s Chevalier de la Légion d’Honneur. \nCLICK TO RSVP
URL:https://events.med.miami.edu/event/deans-distinguished-lecture-drug-pioneer-and-trailblazer-dr-raymond-schinazi/
LOCATION:Lois Pope Life Center\, 1095 Northwest 14th Terrace\, Miami\, FL\, 33136\, United States
CATEGORIES:Pediatrics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261013T120000
DTEND;TZID=America/New_York:20261013T130000
DTSTAMP:20260909T202428Z
CREATED:20260909T202427Z
LAST-MODIFIED:20260909T202428Z
UID:10003793-1791892800-1791896400@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds – "Pediatric Nephrology in Low Resource Settings: Striving for Health Justice" - Melvin Bonilla-Felix\, MD\, FAPP\, FISN
DESCRIPTION:The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.00 hours). \n\n\nMelvin Bonilla-Felix\, MD\, FAPP\, FISN\n\nProfessor\, Section of Nephrology and Hypertension\, \nDepartment of Pediatrics \nUniversity of Puerto Rico – Medical Sciences Campus
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-pediatric-nephrology-in-low-resource-settings-striving-for-health-justice-melvin-bonilla-felix-md-fapp-fisn/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261009T080000
DTEND;TZID=America/New_York:20261009T090000
DTSTAMP:20260930T161214Z
CREATED:20260930T161214Z
LAST-MODIFIED:20260930T161214Z
UID:10003828-1791532800-1791536400@events.med.miami.edu
SUMMARY:From Mutation to Innovation: Tackling BTK Inhibitor Resistance | Justin Taylor\, MD
DESCRIPTION:Justin Taylor\, MD\nPap Corps Champions for Cancer Research Endowed Professor in Leukemia\nDivision of Hematology\, Department of Medicine/Sylvester Comprehensive Cancer Center \nJustin Taylor\, M.D. is an Associate Professor in the Division of Hematology at the University of Miami Miller School of Medicine. He completed his residency at Brigham and Women’s Hospital\, a fellowship at Memorial Sloan Kettering Cancer Center\, and postdoctoral training with Omar Abdel-Wahab\, M.D. \nDr. Taylor’s research focuses on recurrent genetic mutations in hematologic malignancies and the development of targeted therapies. His laboratory employs molecular biology\, single-cell genomics\, and animal models to uncover mechanisms of disease and identify novel therapeutic strategies. His work aims to translate laboratory discoveries into clinical applications to improve outcomes for patients with blood cancers. \nHe has received multiple research grants and has been recognized with Young Investigator Awards from the American Society of Clinical Oncology (ASCO)\, the Hairy Cell Leukemia Foundation\, and the Evans MDS Foundation. In addition to his research\, Dr. Taylor provides clinical care for patients with hematologic malignancies\, integrating cutting-edge scientific insights into personalized treatment plans. \nJOIN HERE!\nDr. Taylor’s objectives: \nDescribe the mechanisms underlying resistance to covalent and non-covalent BTK inhibitors in B-cell malignancies\, including the clinical significance of both kinase-active and kinase-dead BTK mutations. \nEvaluate emerging therapeutic strategies designed to overcome BTK inhibitor resistance\, including targeted protein degradation and other next-generation approaches currently in preclinical and clinical development. \nIntegrate genomic profiling and resistance mutation analysis into the management of patients with CLL and other B-cell malignancies to inform therapeutic decision-making and clinical trial selection. \nFaculty Disclosure\nDr. Taylor has indicated he has the following relevant financial relationships with ineligible companies: \nFinancial Relationship        Commercial Interest/organization \nConsulting Fee                      AstraZeneca\, CARIS Life Sciences \nPlanning Committee Disclosure\nDr. Lekakis has indicated that he has no relevant financial relationships with commercial interests. \nTarget Audience\nFaculty\, Primary Care Physicians\, APRNs\, PharmD \nAccreditation\nThe University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nCredit Designation\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
URL:https://events.med.miami.edu/event/from-mutation-to-innovation-tackling-btk-inhibitor-resistance-justin-taylor-md/
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
ATTACH;FMTTYPE=image/jpeg:https://events.med.miami.edu/wp-content/uploads/2026/09/TAYLOR.jpg
LOCATION:https://miami.zoom.us/j/93768326731?from=addon
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261006T120000
DTEND;TZID=America/New_York:20261006T130000
DTSTAMP:20260909T194605Z
CREATED:20260909T194604Z
LAST-MODIFIED:20260909T194605Z
UID:10003792-1791288000-1791291600@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds -  “Type 1 Diabetes Prevention and Preservation of C-peptide: Results from Clinical Trials and Upcoming Studies.” - David Baidal\, MD
DESCRIPTION:The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.00 hours). \n\n \nDavid Baidal\, M.D.\nAssociate Professor of Clinical Medicine \nDivision of Endocrinology\, Diabetes and Metabolism \nUniversity of Miami Miller School of Medicine
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-type-1-diabetes-prevention-and-preservation-of-c-peptide-results-from-clinical-trials-and-upcoming-studies-david-baidal-md/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Endocrinology,Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261002T080000
DTEND;TZID=America/New_York:20261002T090000
DTSTAMP:20260930T135729Z
CREATED:20260929T153828Z
LAST-MODIFIED:20260930T135729Z
UID:10003827-1790928000-1790931600@events.med.miami.edu
SUMMARY:Lung Cancer's Blind Spots: A Clinician Investigator's Path from the Clinic to Program | Narjust Florez\, MD\, FASCO
DESCRIPTION:Narjust Florez\, MD\nCo-Director Young Lung Cancer Program\,\nMedical Director Cancer Care Access Program\,\nThoracic Medical Oncologist \nDr. Narjust Florez is a thoracic medical oncologist at Dana-Farber Cancer Institute\, an Assistant Professor of Medicine at Harvard Medical School\, the Associate Director of the Cancer Care Equity Program\, and an advocate for diversity in oncology\, becoming the first Latina as Associate Editor in oncology for Diversity\, Equity\, and Inclusion at JAMA Oncology.\n​\nDr. Florez specializes in lung cancer\, particularly early-stage lung cancer\, the development of new targeted therapies\, and the care of young individuals and women with lung cancer. She leads several groundbreaking studies\, including the EQUAL Study which aims to evaluate a new blood test for detecting EGFR-positive lung cancer\, particularly in Hispanic and East Asian communities. Her research ranges from early diagnostic interventions\, therapeutic clinical trials\, survivorship and cancer health disparities. \nA passionate mentor and researcher\, Dr. Florez founded the Florez Lab to support underrepresented medical trainees and improve care for vulnerable populations. She has authored over 145 publications and received numerous awards\, including the 2025 Health Innovators Award by the Boston Business Journal and selected as Boston Top Doctors in 2024 and 2025. In 2024\, she was selected as the youngest Fellow of the Association for Clinical Oncology.  Dr. Florez’s work has been featured in top medical journals and major media outlets\, solidifying her as a leader in both cancer research and social justice in medicine. \nJOIN HERE!\nDr. Florez’s objectives: \n\nDescribe the epidemiology of lung cancer in patients under 50\, in women\, and in never smokers\nExplain the rationale for ctDNA based early detection\nAnalyze the components of a multidisciplinary thoracic oncology program that integrates early-stage trials\, community outreach\, and international collaboration\n\nFaculty Disclosure\nDr. Florez has indicated she has the following relevant financial relationships with ineligible companies: \nFinancial Relationship       Commercial Interest/organization \nGrant or Research                      Support Genentech \, Pfizer \, Daiichi Sankyo\, Inc\, AstraZeneca \nAdvisor                                         Novocure\, Regeneron Pharmaceuticals\,  Inc.\, AstraZeneca\, EMD Serono\, Merck\, Janssen\, Summit Therapeutic\, Lilly \nSpeaker                                        Sanofi S.A \nPlanning Committee Disclosure\nDr. Lekakis has indicated that he has no relevant financial relationships with commercial interests. \nTarget Audience\nFaculty\, Primary Care Physicians\, APRNs\, PharmD \nAccreditation\nThe University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nCredit Designation\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
URL:https://events.med.miami.edu/event/lung-cancers-blind-spots-a-clinician-investigators-path-from-the-clinic-to-program-narjust-florez-md-fasco/
LOCATION:CRB 692\, Clinical Research Building Room: 692
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
ATTACH;FMTTYPE=image/jpeg:https://events.med.miami.edu/wp-content/uploads/2026/09/dr-narjust-florez.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260929T120000
DTEND;TZID=America/New_York:20260929T130000
DTSTAMP:20260908T200829Z
CREATED:20260826T151509Z
LAST-MODIFIED:20260908T200829Z
UID:10003756-1790683200-1790686800@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds – From “Never Steroids” to “Maybe Steroids”: A 30-Year Kawasaki Story - Daniel J Ibanez\, MD
DESCRIPTION:Department of Pediatrics Grand Rounds \nFrom “Never Steroids” to “Maybe Steroids”: A 30-Year Kawasaki Story \nSeptember 29\, 2026 · Hybrid \n\n \n\n\nDate \nTuesday\, September 29\, 2026 \n\n\nTime \n12:00 p.m. – 1:00 p.m. \n\n\nFormat \nHybrid (In Person & Zoom) \n\n\n \n\nSpeaker\n \n\nDaniel J. Ibanez\, M.D.\nAssistant Professor of Clinical Pediatrics \nPediatric Rheumatology \nUniversity of Miami Miller School of Medicine \n\n\n\n \n\nHow to Attend\n\n\nIn Person \nMailman Center \n8th Floor Auditorium\n1601 NW 12th Ave\nMiami\, FL 33136 \nGet Directions \n\n\nVirtual \nJoin the session live on Zoom at 12:00 p.m. \nJoin Zoom \n\n\n\n \n\nAccreditation\n\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.00 hours). \n\n\n \n\nQuestions\n\nContact Nicole Llerena at nxl320@med.miami.edu. \n\n\n \n\nSeries \nDepartment of Pediatrics Grand Rounds
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-from-never-steroids-to-maybe-steroids-a-30-year-kawasaki-story-daniel-j-ibanez-md/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260918T080000
DTEND;TZID=America/New_York:20260918T090000
DTSTAMP:20260916T150417Z
CREATED:20260916T150417Z
LAST-MODIFIED:20260916T150417Z
UID:10003804-1789718400-1789722000@events.med.miami.edu
SUMMARY:Platinum-Resistant Ovarian Cancer: New Directions in Management | Wafa Khadraoui\, MD
DESCRIPTION:Wafa Khadraoui\, MD\nAssistant Professor\nUniversity of Miami\, Sylvester Comprehensive Cancer Center \nDr. Wafa Khadraoui completed her residency in Obstetrics and Gynecology at Yale University/Bridgeport Hospital\, where she served as Education Chief Resident\, followed by a fellowship in Gynecologic Oncology at The Ohio State University. During fellowship\, she pursued a translational research project focused on exosomal biomarkers for the early detection of endometrial cancer. \nIn addition to her translational work\, she has participated and been privileged to authored multiple peer-reviewed publications examining barriers to clinical trial participation\, including disparities in enrollment and the readability of clinical trial consent documents. Her research interests center on improving access to clinical trials\, enhancing patient understanding  \nJOIN HERE!\nDr. Khadraoui’s objectives: \n•Define/review the clinical problem of platinum-resistant ovarian cancer\n•Revise the biology underlying platinum resistance\n•Analyze emerging therapeutic strategies changing management \nFaculty Disclosure\nDr. Khadraoui does not have relevant financial relationships with ineligible companies. \nPlanning Committee Disclosure\nDr. Lekakis has indicated that he has no relevant financial relationships with commercial interests. \nTarget Audience\nFaculty\, Primary Care Physicians\, APRNs\, PharmD \nAccreditation\nThe University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nCredit Designation\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
URL:https://events.med.miami.edu/event/platinum-resistant-ovarian-cancer-new-directions-in-management-wafa-khadraoui-md/
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
ATTACH;FMTTYPE=image/jpeg:https://events.med.miami.edu/wp-content/uploads/2026/09/UM-headshot-scaled-e1789571019688.jpg
LOCATION:https://miami.zoom.us/j/93768326731?from=addon
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260915T120000
DTEND;TZID=America/New_York:20260915T130000
DTSTAMP:20260908T194914Z
CREATED:20260826T151118Z
LAST-MODIFIED:20260908T194914Z
UID:10003755-1789473600-1789477200@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds – "Radiological Diagnosis of Child Abuse" - Edward Dauer\, MD
DESCRIPTION:Department of Pediatrics Grand Rounds \nRadiological Diagnosis of Child Abuse \nSeptember 15\, 2026 · 12:00 p.m. \n\n \n\n\nDate \nTuesday\, September 15\, 2026 \n\n\nTime \n12:00 p.m. – 1:00 p.m. \n\n\nFormat \nHybrid (In Person & Zoom) \n\n\n \n\nSpeaker\n \n\nEdward Dauer\, M.D.\nClinical Professor of Biomedical Engineering\, Radiology\, and Family Medicine \nMember\, University of Miami Board of Trustees \nMember\, Miller School of Medicine Admissions Committee \nUniversity of Miami Miller School of Medicine \nFaculty member for 46 years \n\n\n\n \n\nHow to Attend\n\n\nIn Person \nMailman Center \n8th Floor Auditorium\n1601 NW 12th Ave\nMiami\, FL 33136 \nGet Directions \n\n\nVirtual \nJoin the session live on Zoom at 12:00 p.m. \nJoin Zoom \n\n\n\n \n\nAccreditation\n\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.00 hours). \n\n\n \n\nQuestions\n\nContact Nicole Llerena at nxl320@med.miami.edu. \n\n\n \n\nSeries \nDepartment of Pediatrics Grand Rounds
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-radiological-diagnosis-of-child-abuse-edward-dauer-md/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260908T120000
DTEND;TZID=America/New_York:20260908T130000
DTSTAMP:20260826T150134Z
CREATED:20260826T150105Z
LAST-MODIFIED:20260826T150134Z
UID:10003754-1788868800-1788872400@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds – "Environmental Risk and Susceptibility in Pediatric Lung Disease" - Jelte Kelchtermans\, MD
DESCRIPTION:The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.00 hours). \n\n Jelte Kelchtermans\, MD\nAttending Physician\, Division of Pulmonary and Sleep Medicine\nChildren’s Hospital of Philadelphia
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-environmental-risk-and-susceptibility-in-pediatric-lung-disease-jelte-kelchtermans-md/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260901T120000
DTEND;TZID=America/New_York:20260901T130000
DTSTAMP:20260826T145433Z
CREATED:20260826T145433Z
LAST-MODIFIED:20260826T145433Z
UID:10003753-1788264000-1788267600@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds – “Epinephrine and Anaphylaxis: The Evolution of Current Management" - Matthew Greenhawt\, MD\, MBA\, MSc
DESCRIPTION:The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.00 hours). \n\n Matthew Greenhawt\, MD\, MBA\, MSc\nChief Medical Officer\nAquestive Therapeutics\, Inc
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-epinephrine-and-anaphylaxis-the-evolution-of-current-management-matthew-greenhawt-md-mba-msc/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260811T120000
DTEND;TZID=America/New_York:20260811T130000
DTSTAMP:20260731T201610Z
CREATED:20260731T201610Z
LAST-MODIFIED:20260731T201610Z
UID:10003723-1786449600-1786453200@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds – Development of Non-Genotoxic Cell and Gene Therapies Through the Lens of Fanconi Anemia - Agnieszka Czechowicz\, MD\, PhD
DESCRIPTION:The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.00 hour). \n\n \nAgnieszka Czechowicz\, MD\, PhD\nAssistant Professor of Pediatrics – University Tenure Line (UTL) \nDivision of Hematology\, Oncology\, Stem Cell Transplantation and Regenerative Medicine \nStanford University School of Medicine
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-development-of-non-genotoxic-cell-and-gene-therapies-through-the-lens-of-fanconi-anemia-agnieszka-czechowicz-md-phd/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260626T080000
DTEND;TZID=America/New_York:20260626T090000
DTSTAMP:20260622T160409Z
CREATED:20260617T160548Z
LAST-MODIFIED:20260622T160409Z
UID:10003697-1782460800-1782464400@events.med.miami.edu
SUMMARY:FLT3-Mutated AML: Progress\, Challenges\, and Future Directions | Leticia Campoverde\, MD
DESCRIPTION:Leticia Campoverde\, MD\nHematology Oncology Fellow\nMD Anderson \nDr. Leticia Campoverde is a third-year Hematology–Oncology Fellow at MD Anderson Cancer Center. Originally from Quito\, Ecuador\, she completed medical school at Universidad San Francisco de Quito and Internal Medicine residency at the University of Miami. Her research interests include acute myeloid leukemia\, mechanisms of therapeutic resistance\, targeted therapies\, and clinical outcomes research. Her long-term goal is to become an academic investigator focused on improving outcomes and developing more effective treatments for patients with hematologic malignancies. Dr. Campoverde received the 2026 ASCO Young Investigator Award for her work in FLT3-mutated AML and the 2023 ASCO Conquer Cancer Merit Award for her research in precision oncology. \nJOIN HERE!\nDr. Lunning’s objectives: \n\nAnalyze the biologic and clinical significance of FLT3 mutations in AML\nAnalyze the evolution of FLT3-targeted therapies\nExamine mechanisms of resistance\n\nFaculty Disclosure\nDr. Campoverde does not have relevant financial relationships with ineligible companies. \nPlanning Committee Disclosure\nDr. Lekakis has indicated that he has no relevant financial relationships with commercial interests. \nTarget Audience\nFaculty\, Primary Care Physicians\, APRNs\, PharmD \nAccreditation\nThe University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nCredit Designation\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
URL:https://events.med.miami.edu/event/flt3-mutated-aml-progress-challenges-and-future-directions-leticia-campoverde-md/
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
ATTACH;FMTTYPE=image/jpeg:https://events.med.miami.edu/wp-content/uploads/2026/06/Campoverde_headshot-scaled-e1781712343346.jpg
LOCATION:https://miami.zoom.us/j/93768326731?from=addon
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260619T080000
DTEND;TZID=America/New_York:20260619T090000
DTSTAMP:20260617T160047Z
CREATED:20260617T155755Z
LAST-MODIFIED:20260617T160047Z
UID:10003696-1781856000-1781859600@events.med.miami.edu
SUMMARY:The Journey to CAR-T: Bridging Back Better | Matthew Lunning\, D.O.\, FACP
DESCRIPTION:Matthew Lunning\, D.O.\, FACP\nProfessor & James O. Armitage\, MD\,\nChair of Hematologic Malignancies\nInterim Chief of Hematology\,\nMedical Director of Gene & Cellular Therapy\nAssistant Vice Chancellor for Clinical Research \nMatthew Lunning D.O.\, FACP\, is a Professor with Tenure and Interim Chief in the Division of Hematology at the University of Nebraska Medical Center. Dr. Lunning is also the Assistant Vice Chancellor of Clinical Research\, and Medical Director of Gene & Cellular Therapies. \nHe received his medical degree from Des Moines University in 2006.  Dr. Lunning completed his internal medicine residency at UNMC\, where he served as Chief Medical Resident.  He completed his Hematology/Oncology fellowship and served as the Hematology Chief Fellow at Memorial Sloan-Kettering Cancer Center.  Dr. Lunning returned to UNMC in 2013 and has been active in clinic research\, mentoring\, education\, and patient care. Dr. Lunning was the recipient of the Distinguished Scientist Award in 2019. \nDr. Lunning has served on several National Comprehensive Cancer Network guidelines committees\, including the Immunotherapy Toxicity and T-cell lymphoma panels. He has also served as an invited member of ASCO’s Cancer Education Committee on Non-Hodgkin Lymphoma. He co-organizes the Pan Pacific Lymphoma Conference and Pan Pacific Leukemia Conference. \nJOIN HERE!\nDr. Lunning’s objectives: \n\nDefine and differentiate key CAR-T access and workflow intervals\nEvaluate patient-\, disease-\, and system-level barriers to CAR-T delivery\nCompare contemporary bridging strategies before CAR-T\n\nFaculty Disclosure\nDr. Lunning has indicated he has the following relevant financial relationships with ineligible companies: \nResearch Support | AbbVie\, Genentech\, BMS\nConsultancy | AbbVie\, Astra-Zeneca\, ADC Therapeutics\, BMS\, FATE\, Genentech\, Ipsen\, Incyte\, Kite\, Pfizer\, Recordati \nPlanning Committee Disclosure\nDr. Lekakis has indicated that he has no relevant financial relationships with commercial interests. \nTarget Audience\nFaculty\, Primary Care Physicians\, APRNs\, PharmD \nAccreditation\nThe University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nCredit Designation\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
URL:https://events.med.miami.edu/event/the-journey-to-car-t-bridging-back-better-matthew-lunning-d-o-facp/
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
ATTACH;FMTTYPE=image/jpeg:https://events.med.miami.edu/wp-content/uploads/2026/06/Headshot-Matthew-Lunning-scaled-e1781711984979.jpg
LOCATION:https://miami.zoom.us/j/93768326731?from=addon
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260616T120000
DTEND;TZID=America/New_York:20260616T130000
DTSTAMP:20260608T152724Z
CREATED:20260423T004222Z
LAST-MODIFIED:20260608T152724Z
UID:10003657-1781611200-1781614800@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds – Menstrual Mayhem: A Pediatric Multidisciplinary Approach to Heavy Menstrual Bleeding - Fernando F Corrales-Medina\, MD FAAP & Judy Simms-Cendan\, MD\, FACOG
DESCRIPTION:Department of Pediatrics Grand Rounds \nMenstrual Mayhem: A Pediatric Multidisciplinary Approach to Heavy Menstrual Bleeding \nJune 16\, 2026 · 12:00–1:00 PM · Hybrid Event \n\n \n\nSpeakers\n     \n\n         \n\nFernando F. Corrales-Medina\, M.D.\, FAAP\nAssociate Professor of Clinical Pediatrics\n            Director\, Hemophilia and Thrombosis Comprehensive Treatment Center\n            Medical Director\, Pediatric Hemophilia Program\n            Director\, Pediatric Hematology-Oncology Fellowship Program\n            Division of Pediatric Hematology-Oncology\n            University of Miami Miller School of Medicine \n \n \n     \n\n         \n\nJudy Simms-Cendan\, M.D.\, FACOG\nProfessor\, Division Director\, Pediatric & Adolescent Gynecology\n            Vice Chair for Education\n            Department of Obstetrics\, Gynecology and Reproductive Sciences\n            Courtesy Appointment in Pediatrics\n            University of Miami Miller School of Medicine \n \n \n\n \n\nHow to Attend\n\n\nIn Person \nMailman Center\, 8th Floor Auditorium1601 NW 12th Ave\, Miami\, FL 33136 \n \n\nVirtual \nJoin via ZoomMeeting ID: 976 7789 2224 \n \n \n\n \n\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.00 hour).
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-menstrual-mayhem-a-pediatric-multidisciplinary-approach-to-heavy-menstrual-bleeding-fernando-f-corrales-medina-md-faap-judy-simms-cendan-md/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260609T120000
DTEND;TZID=America/New_York:20260609T130000
DTSTAMP:20260608T152337Z
CREATED:20260521T004955Z
LAST-MODIFIED:20260608T152337Z
UID:10003684-1781006400-1781010000@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds – "Sleepless in Pediatrics: Cracking the Code of Childhood Sleep" - Valeria Munguía\, MD\, FAAP\, FAASM
DESCRIPTION:Department of Pediatrics Grand Rounds \nSleepless in Pediatrics: Cracking the Code of Childhood Sleep \nJune 9\, 2026 · 12:00–1:00 PM · Hybrid Event \n\n \n\nValeria Munguía\, M.D.\, FAAP\, FAASM\nAssistant Professor of Pediatrics and Sleep Medicine \nUniversity of Miami Miller School of Medicine \n\n \n\nHow to Attend\n\n\nIn Person \nMailman Center\, 8th Floor Auditorium1601 NW 12th Ave\, Miami\, FL 33136 \n \n\nVirtual \nJoin via ZoomMeeting ID: 922 8688 9158 \n \n \n\n \n\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.00 hour).
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-sleepless-in-pediatrics-cracking-the-code-of-childhood-sleep-valeria-munguia-md-faap-faasm/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260605T080000
DTEND;TZID=America/New_York:20260605T090000
DTSTAMP:20260601T181155Z
CREATED:20260601T181155Z
LAST-MODIFIED:20260601T181155Z
UID:10003688-1780646400-1780650000@events.med.miami.edu
SUMMARY:Treatment Paradigm of Hepatocellular Carcinoma in 2026 | David Goldberg\, MD
DESCRIPTION:David Goldberg\, MD\nAssociate Professor of Medicine\nDivision of Digestive Health and Liver Diseases\nUniversity of Miami Miller School of Medicine \nDr. David Goldberg is an Associate Professor of Medicine in the Division of Digestive Health and Liver Diseases and Associate Professor of Public Health Sciences at the University of Miami Miller School of Medicine. Dr. Goldberg received his medical degree from the Mount Sinai School of Medicine\, followed by residency in internal medicine at New York Presbyterian Hospital-Columbia University Medical Center. He then completed fellowships in gastroenterology and then transplant hepatology at the University of Pennsylvania\, after which he was a faculty member from 2013-2019 before joining the faculty at the University of Miami Miller School of Medicine in 2019. \nJOIN HERE!\nDr. Goldberg’s objectives: \n\nIdentify the way HCC is staged.\nEvaluate treatment options for HCC based on stage.\nAnalyze the role of liver transplant for HCC.\n\nFaculty Disclosure\nDr. Goldberg has indicated he doesn’t have relevant financial relationships with ineligible companies. \nPlanning Committee Disclosure\nDr. Lekakis has indicated that he has no relevant financial relationships with commercial interests. \nTarget Audience\nFaculty\, Primary Care Physicians\, APRNs\, PharmD \nAccreditation\nThe University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nCredit Designation\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
URL:https://events.med.miami.edu/event/treatment-paradigm-of-hepatocellular-carcinoma-in-2026-david-goldberg-md/
LOCATION:Sylvester Conference Room 1301
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
ATTACH;FMTTYPE=image/webp:https://events.med.miami.edu/wp-content/uploads/2026/06/image.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260602T120000
DTEND;TZID=America/New_York:20260602T130000
DTSTAMP:20260521T005508Z
CREATED:20260429T183452Z
LAST-MODIFIED:20260521T005508Z
UID:10003663-1780401600-1780405200@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds – Consanguinity. Relevance to Patient Care: Current Situation and Future Direction - Klaas J. Wierenga\, MD\, MSc
DESCRIPTION:The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.00 hours). \n\n \n\nKlaas J. Wierenga\, MD\, MSc\nProfessor and Chief \nDivision of Genetics and Metabolism\, Dept of Pediatrics \nUniversity of Florida at Gainesville
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-consanguinity-relevance-to-patient-care-current-situation-and-future-direction-klaas-j-wierenga-md-msc/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260529T080000
DTEND;TZID=America/New_York:20260529T090000
DTSTAMP:20260527T164511Z
CREATED:20260527T164118Z
LAST-MODIFIED:20260527T164511Z
UID:10003687-1780041600-1780045200@events.med.miami.edu
SUMMARY:The epigenetic-splicing synergism in the context of IDH2 and SRSF2 mutations in AML | Aristeidis Telonis\, PhD
DESCRIPTION:Aristeidis G. Telonis\, PhD\nResearch Assistant Professor\nBiochemistry and Molecular Biology\nUniversity of Miami  \nAristeidis G. Telonis\, PhD\, is a Research Assistant Professor in the Department of Biochemistry and Molecular Biology at the University of Miami Miller School of Medicine. His research combines computational biology\, genomics\, and systems-level approaches to study how retrotransposons and other repetitive elements shape gene regulation\, cellular identity\, and disease biology. His lab investigates how these genomic elements respond to environmental stress\, aging\, and therapy\, and how their dysregulation may contribute to cancer and other human diseases. Dr. Telonis’ work integrates high-throughput sequencing\, bioinformatics\, machine learning (AI)\, and molecular data analysis to uncover hidden layers of genome regulation with potential relevance to diagnosis\, prognosis\, and therapeutic response. \nJOIN HERE!\nDr. Telonis’ objectives: \n\nDescribe the expression\, epigenetic and splicing profiles characteristic of IDH2/SRSF2 mutations\nDescribe the relationship of the epigenome with RNA splicing\nExplain how the co-occurance of IDH2 and SRSF2 mutations increases leukemia aggressiveness\n\nFaculty Disclosure\nDr. Telonis has indicated he doesn’t have relevant financial relationships with ineligible companies. \nPlanning Committee Disclosure\nDr. Lekakis has indicated that he has no relevant financial relationships with commercial interests. \nTarget Audience\nFaculty\, Primary Care Physicians\, APRNs\, PharmD \nAccreditation\nThe University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nCredit Designation\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
URL:https://events.med.miami.edu/event/the-epigenetic-splicing-synergism-in-the-context-of-idh2-and-srsf2-mutations-in-aml-aristeidis-telonis-phd/
LOCATION:Sylvester Conference Room 1301
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
ATTACH;FMTTYPE=image/jpeg:https://events.med.miami.edu/wp-content/uploads/2026/05/54413739-aristeidis-telonis.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260526T120000
DTEND;TZID=America/New_York:20260526T130000
DTSTAMP:20260521T005333Z
CREATED:20260521T004050Z
LAST-MODIFIED:20260521T005333Z
UID:10003683-1779796800-1779800400@events.med.miami.edu
SUMMARY:Department of Pediatrics PAS Special Grand Rounds 2026
DESCRIPTION:PAS Special Grand Rounds 2026 Oral Presentations \n   \n\n\n\nName(s)\nPresentation Title\nDivision\n\n\nChryso Pefkaros Katsoufis\nCongenital Anomalies of the Kidney & Urinary Tract (CAKUT) and the Road to ESKD: Prenatal Counseling for At-Risk Newborns \n \nNephrology\n\n\nAshleigh Pyke\, Pingping Chen\, Chenxu Han\, Jonathan Newell\, Liming Chang\, Augusto F. Schmidt\, Shu Wu\, Merline Benny\, Stefan Kurtenbach\, Karen C. Young \n \nHyperoxia Impairs Cardiac Progenitor Maintenance and Cardiomyocyte Maturation in Human iPSC-Derived Heart Organoids\nNeonatology\n\n\nRyan L. Hellinger\, Karan Belday\, Michelina Witte\, Gillian Hotz\nNeighborhood Opportunity and Pediatric Pedestrian and Bicyclist Injuries: Evidence from National and State Data \n \nGeneral\n\n\n\n  \nPAS Special Grand Rounds 2026 Poster Presentations \n  \n\n\n\nName(s)\nPresentation Title\nDivision\n\n\nJeffrey P. Brosco \n \nWell-being of Children and Youth with Special Health Care Needs and Their Families\nPsychology\n\n\nIndrani Mukherjee\, Elise Sintim-Aboagye\, Will Sherman\, Huy Quach\, Neil Ferland\, Katelyn T. Nguyen\, Kamila Otrubova\, Namisha Verma\, Dawn Littlefield\, Sohan Punia\, Erica L. Johnson\, Mark Blackstad\, Mark R. Schleiss\, Clive Gray\, Stellenbosch\, Elizabeth Ann Enninga\, Rana Chakraborty \n \nSpatially Resolved Immune Landscape of the Placenta During Congenital Cytomegalovirus Infection\nInfectious Diseases\n\n\nNelson Claure\, Eduardo H. Bancalari\, Jiaxing Qiu\, Katherine Nash Krahn\, Anna Maria Hibbs\, Juliann Di Fiore\, Namasivayam Ambalavanan\, U Waldemar Carlo\, James S. Kemp\, Zachary A. Vesoulis\, Debra E. Weese- Mayer\, Aaron Hamvas\, Phyllis A. Dennery\, Karen Fairchild \n \nEarly factors associated with cardiorespiratory instability at near term corrected age in preterm infants\nNeonatology\n\n\nAnusha Bai Kalithkar\, Nelson Claure\, Eduardo Bancalari\, Sethuraman Swaminathan \n \nAssociation between Persistent Ductus Arteriosus Severity Score and Treatment Efficacy and Respiratory Outcomes in Extremely Low Birth Weight Infants\nNeonatology\n\n\nShiyu Luo\, Anjali Pawar\, Haoyue sheng\, Nicole Robinson\, Lamrot Tulu\, Casie A. Genetti\, Abdulrahman A. Aldeeri\, Timothy Yu\, Alan H. Beggs\, Klaus Schmitz-Abe\, Qifei Li\, Madesh Chinnathevar Ramesh\, Victtoria O. Ardellini\, Ibrahim Ghemlas\, Khadijah Bakur\, Fowzan S. Alkuraya\,Xiang-Jiao Yang\, Suma P. Shankar\, Pankaj Agrawal \n \nKAT14 as a Novel Gene Associated with Diamond- Blackfan Anemia\nHematology/ Oncology\n\n\nMelissa Gonzalez\, Morgan D. Darabi\, Ruby Natale \n \nBridging Home and School in Early Intervention: Improving Access and Outcomes for Under-Resourced Families\nPsychology\n\n\nElizabeth Rivas\, Tara Gavcovich\, Marissa Janel Defreitas\, Wacharee Seeherunvong\, Carolyn Abitbol\, Jayanthi Chandar\, Garcia Jennifer\, Chryso Katsoufis \n \nDiscordance of creatinine and cystatin C-based estimated glomerular filtration rate measurements in pediatric intestinal transplant patients\nNephrology\n\n\nAlexandra Debure\, Sarah Abushamma\, Kailynn DeRonde\, Nicole A. McElroy\, Brittany Jankauskas\, Maura Alvarez Baumgartner\, Brent D. Rogers\nOptimizing Antibiotic Therapy Duration in the Pediatric Emergency Department\nEmergency Medicine\n\n\n\n 
URL:https://events.med.miami.edu/event/department-of-pediatrics-pas-special-grand-rounds-2026/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260522T080000
DTEND;TZID=America/New_York:20260522T090000
DTSTAMP:20260520T161902Z
CREATED:20260520T161533Z
LAST-MODIFIED:20260520T161902Z
UID:10003682-1779436800-1779440400@events.med.miami.edu
SUMMARY:Expanding the Role of Hereditary Cancer Genetics in Academic Oncology Care | Nicholas A. Borja\, MD
DESCRIPTION:Nicholas A. Borja\, MD\nAssistant Professor of Clinical Genetics\nUniversity of Miami\, Miller School of Medicine  \nDr. Nicholas A. Borja is an Assistant Professor of Clinical Genetics in the Department of Human Genetics and a member of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine\, where he leads the High-Risk Genetics Program.  \nDr. Borja earned his bachelor’s degree from Williams College\, and his medical degree from the University of Pennsylvania School of Medicine. He pursued residency training in general surgery and a research fellowship in cancer biology at the University of Texas Southwestern\, followed by a medical genetics fellowship at the University of Miami/Jackson Health System. \nHis research focuses on hereditary cancer susceptibility\, and he is the principal investigator of the TRACE study\, which aims to identify novel genetic determinants of cancer risk and has received pilot funding from the American Cancer Society. He is also co-investigator for the NIH Undiagnosed Diseases Network Clinical Site of Miami\, where he characterizes ultra-rare genetic disorders and collaborates in gene discovery.  \nDr. Borja has authored studies that broaden the spectrum of phenotypes associated with Nevoid Basal Cell Carcinoma syndrome\, Coffin-Siris syndrome\, Sotos syndrome\, and ATM-related cancer susceptibility\, as well as research on the interplay of genetic and environmental factors in patients who have undergone solid organ transplantation and in those with multiple primary malignancies. \nJOIN HERE!\nDr. Borja’s objectives: \n• Recognize limitations of guideline-based germline testing and identify clinical scenarios in which hereditary cancer susceptibility may be missed.\n• Explain new practices for identifying cancer susceptibility and how this may impact treatment selection\, early detection of cancer\, cascade testing\, and family risk assessment\n• Describe how genome sequencing\, tumor–germline integration\, and emerging technologies can improve diagnostic yield\, provide mechanistic insights\, and enable gene discovery in high-risk cancer patients \nFaculty Disclosure\nDr. Borja has indicated she doesn’t have relevant financial relationships with ineligible companies. \nPlanning Committee Disclosure\nDr. Lekakis has indicated that he has no relevant financial relationships with commercial interests. \nTarget Audience\nFaculty\, Primary Care Physicians\, APRNs\, PharmD \nAccreditation\nThe University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nCredit Designation\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
URL:https://events.med.miami.edu/event/expanding-the-role-of-hereditary-cancer-genetics-in-academic-oncology-care-nicholas-a-borja-md/
LOCATION:Sylvester Conference Room 1301
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
ATTACH;FMTTYPE=image/png:https://events.med.miami.edu/wp-content/uploads/2026/05/Nicholas-A-Borja-headshot-e1779293791285.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260515T120000
DTEND;TZID=America/New_York:20260515T130000
DTSTAMP:20260511T210500Z
CREATED:20260511T210500Z
LAST-MODIFIED:20260511T210500Z
UID:10003679-1778846400-1778850000@events.med.miami.edu
SUMMARY:Mailman Center Grand Rounds - Pediatric Dysphonia: Not Just a Hoarse Voice
DESCRIPTION:Friday\, May 15 | 12:00 pm – 1:00 pm | Register\nGuest Speakers:\nRobert Fritz\, SLP\nDepartment of Otolaryngology\, Division of Speech Pathology\nMaria Murljacic\, SLP\nVoice Specialist\, Department of Otolaryngology\, Division of Speech Patholoy\nFor children\, chronic hoarseness can have significant impact on social emotional development and can serve as a marker of underlying upper airway conditions. This presentation will provide an overview of pediatric voice evaluation and care\, including a review of basic vocal physiology\, common etiologies of voice impairment in children\, and approaches to interdisciplinary management for clinicians and physicians. \nLearning Objectives:\n– Participants will describe the social and emotional impact of voice and upper airway disorders in children.\n– Participants will identify abnormal voice in children and implement robust referral pathway for evaluation and treatment. \nCredit Designation:\n– Florida Board for LCSW\, LMFT and LMHC approved 1 CE credit. Provider # BAP Exp. Date 3/31/2027.\n– 1 CE credit approved for psychology. Mailman Center is approved by the American Psychological Association to sponsor continuing education for psychologists.\n– 0.1 ASHA CEU
URL:https://events.med.miami.edu/event/mailman-center-grand-rounds-pediatric-dysphonia-not-just-a-hoarse-voice/
LOCATION:Zoom
CATEGORIES:Mailman Center for Child Development,Pediatrics
ORGANIZER;CN="Roselyne Antao":MAILTO:rantao@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260515T080000
DTEND;TZID=America/New_York:20260515T090000
DTSTAMP:20260514T202416Z
CREATED:20260514T202257Z
LAST-MODIFIED:20260514T202416Z
UID:10003680-1778832000-1778835600@events.med.miami.edu
SUMMARY:Optimal Management of Localized Pancreatic Adenocarcinoma- A Surgeon's Approach | Caitlin Hester\, MD
DESCRIPTION:Caitlin Hester\, MD\nAssistant Professor of Surgery\nUniversity of Miami \nDr. Caitlin Hester is a board-certified surgeon and specializes in minimally invasive and open operations for gastrointestinal malignancies with a focus on cancers of the liver\, pancreas\, bile duct\, and stomach.  She obtained her medical degree from Medical College of Georgia.  She completed seven years of general surgery training at the University of Texas Southwestern and a two-year Complex General Surgical Oncology fellowship at MD Anderson Cancer Center. \nHer clinical research aimed at studying the genotypic and phenotypic profiles of pancreatic tumors and mechanisms that may contribute to treatment sensitivity. She plans to integrate response to therapy into clinical trial design in hopes of individualizing treatment plans for patients. \nShe has served as the Quality Improvement Fellow Officer at MD Anderson Cancer Center and as a representative on the Diversity\, Equity\, and Inclusion Committee for the Department of Surgery at UT Southwestern Medical Center.  She is passionate about DEI work and has dedicated a significant amount of time to community service efforts directed toward improving educational opportunities and early exposure to the field of medicine for underrepresented minorities. \nShe was awarded the Gary Purdue Chief Resident of the Year Award at the University of Texas Southwestern for exemplifying clinical excellence and dedication to patient care.\nIt is her greatest privilege to care for patients with cancer\, and it is her mission to provide every opportunity to improve quality of life and longevity for her patients. \nJOIN HERE!\nDr. Hester’s objectives: \n• Distinguish resectable\, borderline resectable\, and locally advanced PDAC\n• Analyze the ideal duration and sequence of chemotherapy for resectable\, borderline resectable\, and locally advanced PDAC\n• Be able to describe the treatment arms and outcomes of the following trials: PRODIGE 24\, SWOG S1505\, Alliance A201501\, and CASSANDRA \nFaculty Disclosure\nDr. Hester has indicated she doesn’t have relevant financial relationships with ineligible companies. \nPlanning Committee Disclosure\nDr. Lekakis has indicated that he has no relevant financial relationships with commercial interests. \nTarget Audience\nFaculty\, Primary Care Physicians\, APRNs\, PharmD \nAccreditation\nThe University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nCredit Designation\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
URL:https://events.med.miami.edu/event/optimal-management-of-localized-pancreatic-adenocarcinoma-a-surgeons-approach-caitlin-hester-md/
LOCATION:Sylvester Conference Room 1301
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
ATTACH;FMTTYPE=image/jpeg:https://events.med.miami.edu/wp-content/uploads/2026/05/Headshot-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260512T120000
DTEND;TZID=America/New_York:20260512T130000
DTSTAMP:20260509T171959Z
CREATED:20260423T160055Z
LAST-MODIFIED:20260509T171959Z
UID:10003659-1778587200-1778590800@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds – "Transcatheter Interventions in Congenital Heart Disease: A Transformative Journey" - Satinder K Sandhu\, M.D.
DESCRIPTION:Department of Pediatrics Grand Rounds \n“Transcatheter Interventions in Congenital Heart Disease: A Transformative Journey” \nTuesday\, May 12\, 2026 · 12:00 PM – 1:00 PM \n\n \n\n\n📍 Format \nHybrid (In-Person & Zoom) \n \n\n🕐 Time \n12:00 PM – 1:00 PM \n \n\n📜 CME Credit \n1.00 AMA PRA Category 1™ \n \n\n \n\n    Join Zoom\n\n \n\nFeatured Speaker\n\n         \n\nSatinder K Sandhu\, M.D. \nProfessor of Clinical Pediatric Cardiology \nUniversity of Miami Miller School of Medicine \n \n \n\n \n\nCME Accreditation\n\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.00 hours). \n \n\n \n\nVenue\n\n\nIn-Person \nMailman Center \n8th Floor Auditorium \n1601 NW 12th AveMiami\, FL 33136 \n            📍 View on Google Maps\n        \n\nVirtual \nJoin via Zoom \n            Join Zoom\n        \n \n\n \n\nQuestions?\n\nNicole Llerena \nnxl320@med.miami.edu
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-transcatheter-interventions-in-congenital-heart-disease-a-transformative-journey-satinder-k-sandhu-m-d/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260508T080000
DTEND;TZID=America/New_York:20260508T090000
DTSTAMP:20260506T143845Z
CREATED:20260506T143128Z
LAST-MODIFIED:20260506T143845Z
UID:10003676-1778227200-1778230800@events.med.miami.edu
SUMMARY:Mortality and Morbidity Conference | Drs. Briski and Tuerff
DESCRIPTION:📅 Friday\, May 8\, 2026\n🕐 8:00 AM – 9:00 AM\n📍 Virtual Event\nJoin Zoom\n\n \n\nHematology / Medical Oncology Grand Rounds \n“Mortality and Morbidity Conference” \n\n \n\n \n\n Robert Briski\, MD and Daniel Tuerff\, MD \nFellow \nUniversity of Miami / JMH \n\n\n \n\nAbout Drs. Tuerff and Briski\nDr. Briski completed his medical school at Wayne State University School of Medicine\, performed his residency in internal medicine at the University of Miami\, where he stayed an extra year as a chief resident\, he completed a two-year leukemia fellowship at The University of Texas MD Anderson Cancer Center where he focused on early phase clinical trials\, and is a rising third year chief fellow at the University of Miami. \n\nDr. Tuerff completed medical school at Wake Forest in NC\, and his residency in IM at George Washington.  He is one of the rising chiefs next year and is interested in GI and cutaneous oncology. \n \n\nLearning Objectives\nAt the conclusion of this activity\, participants will be able to: \n\n\nDr. Briski’s Objectives:\n• Analyze diagnostic criteria for MGRS.\n• Analyze MGRS treatment response criteria.\n• Illustrate the benefit of using root cause analysis to develop an action plan. \nDr. Tuerff’s Objectives:\n• Analyze a specific case and explore preventative measures that could have been implemented.\n• Revise the effect of steroids on the diagnosis of hematologic malignancies.\n• Optimize transitions of care between health systems and teams. \n\n\n\n \n\nTarget Audience: Faculty\, Primary Care Physicians\, APRNs\, PharmD \n\n \n\nVenue\n\nVirtual Event \nJoin via Zoom \nJoin Zoom \n\n\n \n\nDisclosures\n\nCommercial Interests \nDrs. Briski and Tuerff have indicated that they don’t have relevant financial relationships with ineligible companies. \n\n\n \n\nEvent Category\nDept. of Medicine · Hematology · Medical Oncology · Grand Rounds \n\n \n\nHematology / Medical Oncology Grand Rounds \nFriday\, May 8\, 2026 · 8:00 AM – 9:00 AM · Virtual Event \nJoin Zoom
URL:https://events.med.miami.edu/event/mortality-and-morbidity-conference-drs-briski-and-tuerff/
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
ATTACH;FMTTYPE=image/jpeg:https://events.med.miami.edu/wp-content/uploads/2026/05/Headshot-e1778078318478.jpg
LOCATION:https://miami.zoom.us/j/92524015404
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260505T120000
DTEND;TZID=America/New_York:20260505T130000
DTSTAMP:20260501T190448Z
CREATED:20260428T225812Z
LAST-MODIFIED:20260501T190448Z
UID:10003662-1777982400-1777986000@events.med.miami.edu
SUMMARY:Department of Pediatrics Grand Rounds – Beyond Snoring: Cardiometabolic Consequences of Obstructive Sleep Apnea in Children - Agustin Cabrera\, M.D.
DESCRIPTION:Department of Pediatrics Grand Rounds \n“Beyond Snoring: Cardiometabolic Consequences of Obstructive Sleep Apnea in Children” \nMonday\, May 5\, 2026 · 12:00 PM – 1:00 PM \n\n \n\n\n📍 Format \nHybrid (In-Person & Zoom) \n \n\n🕐 Time \n12:00 PM – 1:00 PM \n \n\n📜 CME Credit \n1.00 AMA PRA Category 1™ \n \n\n \n\n    Join Zoom\n\n \n\nFeatured Speaker\n\n         \n\nAgustin Cabrera\, M.D. \nAssistant Professor of Clinical\, Pediatric Pulmonary \nUniversity of Miami Miller School of Medicine \n \n \n\n \n\nCME Accreditation\n\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ (1.00 hours). \n \n\n \n\nVenue\n\n\nIn-Person \nMailman Center \n8th Floor Auditorium \n1601 NW 12th AveMiami\, FL 33136 \n            📍 View on Google Maps\n        \n\nVirtual \nJoin via Zoom \n            Join Zoom\n        \n \n\n \n\nQuestions?\n\nNicole Llerena \nnxl320@med.miami.edu
URL:https://events.med.miami.edu/event/department-of-pediatrics-grand-rounds-beyond-snoring-cardiometabolic-consequences-of-obstructive-sleep-apnea-in-children-agustin-cabrera-m-d/
LOCATION:Mailman Center\, 1601 NW 12th Ave\, MIami\, 33136\, United States
CATEGORIES:Pediatrics
ORGANIZER;CN="Nicole Llerena":MAILTO:nxl320@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260501T080000
DTEND;TZID=America/New_York:20260501T090000
DTSTAMP:20260501T185936Z
CREATED:20260430T155538Z
LAST-MODIFIED:20260501T185936Z
UID:10003664-1777622400-1777626000@events.med.miami.edu
SUMMARY:Osteosarcoma Treatment: A Journey into the Tumor Microenvironment | Emanuela Palmerini\, MD\, PhD
DESCRIPTION:Hematology/Medical Oncology Grand Rounds \n“Osteosarcoma Treatment: A Journey into the Tumor Microenvironment” \nThursday\, May 1\, 2026 · 8:00 AM – 9:00 AM \n1.0 AMA PRA Category 1 Credit™ · 1.0 ABIM MOC Points\n\n \n\n\n📍 Format \nVirtual (Zoom) \n\n\n🕐 Time \n8:00 AM – 9:00 AM \n\n\n🎯 Audience \nFaculty\, PCPs\, APRNs\, PharmD \n\n\n \nJoin Zoom\n \n\nFeatured Speaker\n \n\nEmanuela Palmerini\, M.D.\, Ph.D. \nProfessor of Clinical Medicine \nUniversity of Miami Miller School of Medicine \nDr. Palmerini is a medical oncologist and international expert in bone and soft tissue sarcomas. She is Full Professor of Sarcoma Research at the Miller School of Medicine and a member of the Sarcoma and Phase I Programs at Sylvester Comprehensive Cancer Center. She has led or contributed to more than 30 sarcoma clinical trials and has played key roles in major European research networks\, including the EORTC Bone Sarcoma Group\, the Euro-Ewing Consortium\, and as co-Chair of the FOSTER osteosarcoma consortium. She has authored over 200 scientific publications. \n\n\n\n \n\nLearning Objectives\n\n\nAnalyze current and emerging therapeutic strategies in osteosarcoma\, including MAP chemotherapy\, mifamurtide\, and novel immunotherapies such as ADCs and T-cell engagers. \n\n\nRecognize the prognostic relevance of the tumor microenvironment\, particularly the impact of CD8+ T cells\, NK cells\, Tregs\, and CD4+ infiltration on survival. \n\n\nApply patient-centered\, multidisciplinary decision-making through sarcoma expert consultation. \n\n\n\n \n\nAccreditation & Credits\n\n\nAccreditation \nThe University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \n\n\nCredit Designation \nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. \n\n\n\n \n\nDisclosures\n\nDr. Palmerini: Membership on Advisory Committees or Review Panels\, Board Membership – Deciphera Pharmaceuticals \nDr. Lekakis (Planning Committee): No relevant financial relationships
URL:https://events.med.miami.edu/event/osteosarcoma-treatment-a-journey-into-the-tumor-microenvironment-emanuela-palmerini-md-phd/
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
LOCATION:https://miami.zoom.us/j/93768326731?from=addon
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260424T120000
DTEND;TZID=America/New_York:20260424T130000
DTSTAMP:20260414T174812Z
CREATED:20260414T174812Z
LAST-MODIFIED:20260414T174812Z
UID:10003650-1777032000-1777035600@events.med.miami.edu
SUMMARY:Mailman Center Grand Rounds - Framing the Landscape: Autism in Adulthood & Mental Health Needs
DESCRIPTION:Framing the Landscape: Autism in Adulthood & Mental Health Needs\nGuest Speaker: Dolly Marie Ferraiuolo\, PhD\, LCSW-QS\, CST\nBoard Certified Doctor of Sexology\, Licensed Clinical Social Worker\nApril 24\, 2026 | 12:00pm – 1:00pm | Register here  \nThis presentation explores how autism presents in adulthood and examines the persistent barriers autistic adults face in accessing effective\, affirming mental health care. Attendees will gain a deeper understanding of the clinical and systemic gaps that contribute to misdiagnosis\, masking\, and poor treatment experiences\, while also learning practical\, evidence-informed strategies to better support autistic adults in therapeutic settings. The session integrates current research\, clinical application and lived experience perspective to help providers create more accessible neurodiversity-affirming care. \nLearning Objectives: \n– Identify common barriers autistic adults face in accessing and engaging with mental health care\, including masking\, diagnostic overshadowing\, and environmental or communication mismatches.\n– Apply neurodiversity-affirming\, evidence-informed strategies to improve therapeutic accessibility\, rapport\, and treatment outcomes for autistic adults. \nCredit Designation:  \n– Florida Board for LCSW\, LMFT and LMHC approved 1 CE credit\, Provider # BAP Exp. Date 3/31/2027.\n– 1 CE credit approved for psychology. Mailman Center is approved by the American Psychological Association to sponsor continuing education for psychologists.\n– 0.1 ASHA CEU \nSpeaker Disclosures:  \n– Relevant Financial Relationship: Receives a salary from SHARE of Florida for ownership interest.\n– Relevant Non-Financial Relationship: Board member/Center for Autism and Related Disorders (CARD).
URL:https://events.med.miami.edu/event/mailman-center-grand-rounds-framing-the-landscape-autism-in-adulthood-mental-health-needs/
LOCATION:Zoom
CATEGORIES:Mailman Center for Child Development,Pediatrics
ORGANIZER;CN="Roselyne Antao":MAILTO:rantao@med.miami.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260424T080000
DTEND;TZID=America/New_York:20260424T090000
DTSTAMP:20260421T154434Z
CREATED:20260421T154208Z
LAST-MODIFIED:20260421T154434Z
UID:10003653-1777017600-1777021200@events.med.miami.edu
SUMMARY:One Click. Unified team. Faster Relief: Sylvester’s New Weekly Adult Cancer Pain & Bone Metastasis Tumor Board | Alan A. Sag\, MD\, FSIR
DESCRIPTION:Alan A. Sag\, MD\, FSIR\nAssociate Professor of Interventional Radiology\nUniversity of Miami \nAlan Alper Sag\, MD\, FSIR has a decade of interventional oncology experience after training at Memorial Sloan Kettering Cancer Center and served as joint faculty in Orthopaedic Surgery and Interventional Radiology at Duke University. He was selected to represent Duke nationally as the only Interventional Radiologist on the NCCN Adult Cancer Pain Guidelines Committee.  In 2025 he co-founded the Adult Cancer Pain & Bone Metastasis tumor board which he currently leads and moderates (https://news.med.miami.edu/sylvester-launches-tumor-board-dedicated-to-cancer-pain/.) \nIn 2026 he led a task force within the Society of Interventional Radiology to successfully amend the NCCN Adult Cancer Pain Guidelines v.2026 to increase inclusion of cancer pain interventions. He is a national society masterclass-level operator for minimally-invasive bone (spine tumor ablation\, kyphoplasty\, vertebroplasty\, acetabuloplasty\, sacroplasty\, cryoablation\, RFA\, bone tumor embolization\, genicular artery embolization) and nerve (nerve blocks\, cryoneurolysis\, nerve ablation including basivertebral nerve ablation and geniculate nerve ablation) interventions\, with subspecialty expertise in Interventional Oncology for Liver (y90 radioembolization\, TACE/chemoembolization\, bland embolization\, microwave\, cryoablation) and Kidney (RCC embolization\, microwave ablation\, cryoablation). \nJOIN HERE!\nDr. Sag’s objectives: \n\nApply the new Epic referral “Cancer Pain Tumor Board” or “APPT35”\nApply the new Epic chat group “Pain Tumor Board”\nAnalyze efficiency and utility of multidisciplinary referral via actual case-based review of patients treated via Cancer Pain tumor board.\n\nFaculty Disclosure\nDr. Sag has indicated that he has the following relevant financial relationships with ineligible companies: \nMembership on Advisory Committees or Review Panels\, Board Membership\, etc. | Varian Medical System \nPlanning Committee Disclosure\nDr. Lekakis has indicated that he has no relevant financial relationships with commercial interests. \nTarget Audience\nFaculty\, Primary Care Physicians\, APRNs\, PharmD \nAccreditation\nThe University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nCredit Designation\nThe University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity\, which includes participation in the evaluation component\, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
URL:https://events.med.miami.edu/event/one-click-unified-team-faster-relief-sylvesters-new-weekly-adult-cancer-pain-bone-metastasis-tumor-board-alan-a-sag-md-fsir/
CATEGORIES:Dept. of Medicine,Hematology,Medical Oncology,Pediatrics
ATTACH;FMTTYPE=image/jpeg:https://events.med.miami.edu/wp-content/uploads/2026/04/sag-alan-1326202268.jpg
LOCATION:https://miami.zoom.us/j/93768326731?from=addon
END:VEVENT
END:VCALENDAR